Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients

por Casadei, Beatrice, Argnani, Lisa, Morigi, Alice, Lolli, Ginevra, Broccoli, Alessandro, Pellegrini, Cinzia, Nanni, Laura, Stefoni, Vittorio, Coppola, Paolo Elia, Carella, Matteo, Cavo, Michele, Zinzani, Pier Luigi
Publicado 2020

Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087

por Chen, Robert, Armand, Phillippe, Fanale, Michelle A, Ribrag, Vincent, Zinzani, Pier Luigi, Ricart, Alejandro D, Thompson, Seth, Balakumaran, Arun, Molin, Daniel, Shipp, Margaret A, Moskowitz, Craig H
Publicado 2015

Diagnostic accuracy of positron emission tomography/computed tomography-driven biopsy for the diagnosis of lymphoma

por Broccoli, Alessandro, Nanni, Cristina, Cappelli, Alberta, Bacci, Francesco, Gasbarrini, Alessandro, Tabacchi, Elena, Piovani, Carlo, Argnani, Lisa, Ghermandi, Riccardo, Sabattini, Elena, Golfieri, Rita, Fanti, Stefano, Zinzani, Pier Luigi
Publicado 2020

Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia

por Broccoli, Alessandro, Terragna, Carolina, Nanni, Laura, Martello, Marina, Armuzzi, Silvia, Agostinelli, Claudio, Morigi, Alice, Casadei, Beatrice, Pellegrini, Cinzia, Stefoni, Vittorio, Sabattini, Elena, Argnani, Lisa, Zinzani, Pier Luigi
Publicado 2021

Italian Real-Life Experience on the Use of Mogamulizumab in Patients with Cutaneous T-Cell Lymphomas

por Caruso, Laura, Castellino, Alessia, Dessì, Daniela, Flenghi, Leonardo, Giordano, Antonio, Ibatici, Adalberto, Massone, Cesare, Pileri, Alessandro, Proietti, Ilaria, Pupo, Livio, Quaglino, Pietro, Rupoli, Serena, Zinzani, Pier Luigi
Publicado 2022

90‐yttrium‐ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high‐risk follicular lymphoma: updated long‐term results after a median follow...

por Casadei, Beatrice, Pellegrini, Cinzia, Pulsoni, Alessandro, Annechini, Giorgia, De Renzo, Amalia, Stefoni, Vittorio, Broccoli, Alessandro, Gandolfi, Letizia, Quirini, Federica, Tonialini, Lorenzo, Morigi, Alice, Argnani, Lisa, Zinzani, Pier Luigi
Publicado 2016

Successful Pregnancies, Births, and Children Development Following Oocyte Cryostorage in Female Cancer Patients During 25 Years of Fertility Preservation

por Porcu, Eleonora, Cipriani, Linda, Dirodi, Maria, De Iaco, Pierandrea, Perrone, Anna Myriam, Zinzani, Pier Luigi, Taffurelli, Mario, Zamagni, Claudio, Ciotti, Patrizia Maria, Notarangelo, Leonardo, Calza, Nilla, Damiano, Giuseppe
Publicado 2022

Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma

por Derenzini, Enrico, Agostinelli, Claudio, Imbrogno, Enrica, Iacobucci, Ilaria, Casadei, Beatrice, Brighenti, Elisa, Righi, Simona, Fuligni, Fabio, Di Rorà, Andrea Ghelli Luserna, Ferrari, Anna, Martinelli, Giovanni, Pileri, Stefano, Zinzani, Pier Luigi
Publicado 2015

Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphoma

por Derenzini, Enrico, Iacobucci, Ilaria, Agostinelli, Claudio, Imbrogno, Enrica, Storlazzi, Clelia Tiziana, L`Abbate, Alberto, Casadei, Beatrice, Ferrari, Anna, Di Rora`, Andrea Ghelli Luserna, Martinelli, Giovanni, Pileri, Stefano, Zinzani, Pier Luigi
Publicado 2015

ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study

por Giladi, Odil, Bagnato, Gianmarco, Gentilini, Marianna, Shimony, Shai, Pasvolsky, Oren, Berger, Tamar, Itchaki, Gilad, Raanani, Pia, Broccoli, Alessandro, Stefoni, Vittorio Stefoni, Lolli, Ginevra, Argnani, Lisa, Zinzani, Pier Luigi, Gurion, Ronit
Publicado 2022

Poster: ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study

por Giladi, Odil, Bagnato, Gianmarco, Gentilini, Marianna, Shimony, Shai, Pasvolsky, Oren, Berger, Tamar, Itchaki, Gilad, Raanani, Pia, Broccoli, Alessandro, Stefoni, Vittorio Stefoni, Lolli, Ginevra, Argnani, Lisa, Zinzani, Pier Luigi, Gurion, Ronit
Publicado 2022

The safety and clinical effectiveness of rapid infusion with CT‐P10 in patients with non‐Hodgkin's lymphoma or chronic lymphocytic leukemia: A retrospective non‐interventional post...

por Bishton, Mark, Marshall, Scott, Harchowal, Jatinder, Salles, Gilles, Golfier, Camille, Tucci, Alessandra, Fernández, Alicia Rodriguez, Sanchez Blanco, Jose Javier, Bocchia, Monica, Kim, SooKyoung, Lee, Young Nam, Zinzani, Pier Luigi
Publicado 2022

Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up

por Zinzani, Pier Luigi, Santoro, Armando, Gritti, Giuseppe, Brice, Pauline, Barr, Paul M., Kuruvilla, John, Cunningham, David, Kline, Justin, Johnson, Nathalie A., Mehta-Shah, Neha, Lisano, Julie, Wen, Rachael, Akyol, Alev, Moskowitz, Alison J.
Publicado 2023

P010: Inferior Outcomes for Young Adults Treated on Advanced Stage Clinical Trials: Report from the HoLISTIC Consortium

por Parsons, Susan K., Rodday, Angie Mae, Friedberg, Jonathan W., Gallamini, Andrea, Hawkes, Eliza, Hodgson, David, Johnson, Peter, Link, Brian, Maurer, Matthew, Nelson, Jason, Savage, Kerry J., Upshaw, Jenica, Zinzani, Pier Luigi, Evens, Andrew M.
Publicado 2022

Multidimensional Results and Reflections on CAR-T: The Italian Evidence

por Foglia, Emanuela, Garagiola, Elisabetta, Ladisa, Vito, Rambaldi, Alessandro, Cairoli, Roberto, Sammassimo, Simona, Salè, Emanuela Omodeo, Zinzani, Pier Luigi, Esposti, Marco, Alberti, Luisa, Mulas, Maria Franca, Melis, Eleonora, Onnis, Stefania, Marcias, Maurizio, Satta, Vittorio, Croce, Davide
Publicado 2023

Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase...

por Zinzani, Pier Luigi, Khuageva, Nuriet K, Wang, Huaqing, Garicochea, Bernardo, Walewski, Jan, Van Hoof, Achiel, Soubeyran, Pierre, Caballero, Dolores, Buckstein, Rena, Esseltine, Dixie-Lee, Theocharous, Panteli, Enny, Christopher, Zhu, Eugene, Elsayed, Yusri A, Coiffier, Bertrand
Publicado 2012

T058: Safety and Dose-Expansion Study of Combination Favezelimab (anti–LAG-3) Plus Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma Refractory to An...

por Timmerman, John, Lavie, David, Johnson, Nathalie A., Avigdor, Abraham, Borchmann, Peter, Andreadis, Charalambos, Bazargan, Ali, Gregory, Gareth, Keane, Colm, Tzoran, Inna, Vucinic, Vladan, Zinzani, Pier Luigi, Zhang, Hong, Pillai, Pallavi, Nahar, Akash, Herrera, Alex F.
Publicado 2022

Methodological framework for radiomics applications in Hodgkin’s lymphoma

por Sollini, Martina, Kirienko, Margarita, Cavinato, Lara, Ricci, Francesca, Biroli, Matteo, Ieva, Francesca, Calderoni, Letizia, Tabacchi, Elena, Nanni, Cristina, Zinzani, Pier Luigi, Fanti, Stefano, Guidetti, Anna, Alessi, Alessandra, Corradini, Paolo, Seregni, Ettore, Carlo-Stella, Carmelo, Chiti, Arturo
Publicado 2020

Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience

por Casadei, Beatrice, Argnani, Lisa, Guadagnuolo, Serafina, Pellegrini, Cinzia, Stefoni, Vittorio, Broccoli, Alessandro, Nanni, Laura, Morigi, Alice, Lolli, Ginevra, Guarino, Maria, Spinardi, Luca, Pierucci, Elisabetta, Fanti, Stefano, Bartoletti, Michele, Dicataldo, Michele, Sabattini, Elena, Bonifazi, Francesca, Zinzani, Pier Luigi
Publicado 2021

Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana Linfomi

por Ballotta, Laura, Zinzani, Pier Luigi, Pileri, Stefano, Bruna, Riccardo, Tani, Monica, Casadei, Beatrice, Tabanelli, Valentina, Volpetti, Stefano, Luminari, Stefano, Corradini, Paolo, Lucchini, Elisa, Tisi, Maria Chiara, Merli, Michele, Re, Alessandro, Varettoni, Marzia, Pesce, Emanuela Anna, Zaja, Francesco
Publicado 2021